Innovations Targeting Adaptive Immune Mechanisms against Viral Pathogens

Moderator(s)

• RB

  Rachel Bonami

  Vanderbilt University Medical Center
• RO

  Robin Orozco

  Univ. of Kansas

Presentations:

• 3:45 PM - 4:00 PM US ET

  GLUT1 in Memory CD4+ T-cells Correlates with Sustained Antibody Responses and Polyfunctionality Post-RSV Vaccination in Immunocompromised Individuals
  

  Author: Nirvani P. Jairam, BS – Johns Hopkins Univ. Sch. of Med.
• 4:00 PM - 4:15 PM US ET

  Processing-Optimized Multi-Epitope mRNA Vaccine Enhances HIV-1–Specific CD8⁺ T Cells
  

  Author: Takuto Nogimori, PhD (he/him/his) – National Institutes of Biomedical Innovation, Health and Nutrition
• 4:15 PM - 4:30 PM US ET

  Toward a Pan-Arenavirus T-cell Vaccine: Identification and Preclinical Evaluation of Conserved Epitope constructs
  

  Author: Ziyin Wang, PhD – La Jolla Inst. for Immunol.
• 4:30 PM - 4:45 PM US ET

  Development of T-cell-based immunotherapy against chronic Hepatitis B infection
  

  Author: Sofiya Yusova, MS (she/her/hers) – OHSU Oregon National Primate Research Center
• 4:45 PM - 5:00 PM US ET

  An HIV V1V2 mRNA-LNP vaccine induces strong, cross-clade functional antibody responses in mice and rhesus macaques
  

  Author: Catarina Hioe – Icahn School of Medicine, Mount Sinai
• 5:00 PM - 5:15 PM US ET

  Imprinted antibody lineages can persist for half a century and dominate cross-neutralizing recall responses to poliovirus
  

  Author: Jason Lavinder, PhD – University of Texas, Austin